Darou Pakhsh
Company type | Public |
---|---|
TSE: DARO1 ISIN: IRO1DARO0008 | |
Industry | Pharmaceuticals, chemicals |
Founded | 1956 1997 (as Darou Pakhsh Holding) | (as Darou Pakhsh)
Headquarters | Tehran , Iran |
Area served | Worldwide |
Products | Veterinary drugs, diagnostic imaging, general and specialty medicines, women's health products, over-the-counter drugs, diabetes care, pesticides, plant biotechnology |
Owner | TPICO (74.5%)[1] |
Website | www.dpholding.com |
Darou Pakhsh Holding Company (Persian: شرکت کارخانجات داروپخش, Shirkæt-e Karxanujat-e Darvipaxesh, lit. drug distribution company) is a major pharmaceutical company in Iran. The company is majority-owned by the Social Security Organization of Iran. The company manufactures, distributes, imports and exports finished products and pharmaceutical raw materials. Darou Pakhsh has an annual turnover of US$400m and claims to have the largest research and development operation of any Iranian drug firm.[2] The company formed a plasmapheresis joint venture with a German medical firm, Biotest AG, in early 2004.[2] Darou Pakhsh is listed on the Tehran Stock Exchange.
History[edit]
Initially, the plant had been designed to produce 20 dosage forms.
See also[edit]
References[edit]
- ^ "Daroupakhsh ( DARO1 ) info". tsetmc.com. Retrieved 2012-05-26.
- ^ a b IRAN: Healthcare and Pharmaceuticals Forecast, Economist Intelligence Unit, August 18, 2008